-
2025-521640-38-00
5
2025-10-16
Focal onset seizures or primary generalized tonic-clonic seizures.
-
2024-516234-35-00
9
2025-10-15
Relapsed or Refractory B-Cell Malignancies
-
2025-521377-14-00
4
2025-10-06
Atrial fibrillation
-
2024-519827-16-00
5
2025-09-30
Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients
-
2024-519875-24-00
5
2025-09-26
Carcinoid syndrome
-
2024-520210-21-00
5
2025-09-19
Crohn’s Disease
-
2025-520740-16-00
5
2025-09-19
Primary Aldosteronism defined by excess aldosterone secretion
-
2024-511993-55-00
4
2025-09-18
bile acid diarrhoea (BAD)
-
2024-515516-50-00
4
2025-09-18
Osteogenesis Imperfecta
-
2024-519814-29-00
4
2025-09-12
Advanced or Metastatic Non-small Cell Lung Cancer
-
2024-513171-41-00
5
2025-09-11
Vitiligo
-
2024-516982-35-00
5
2025-09-11
Ovarian Cancer
-
2024-519152-82-00
5
2025-09-03
Relapsed/Refractory Follicular Lymphoma
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-515484-54-00
4
2025-09-01
decompensated cirrhosis
-
2024-518914-18-00
4
2025-08-27
Moderate to Severely Active Ulcerative Colitis & Moderate to Severely
-
2025-520981-23-00
4
2025-08-26
Idiopathic Hypersomnia (IH)
-
2024-517529-26-00
5
2025-08-04
Chronic Inflammatory Demyelinating Polyneuropathy
-
2022-502983-19-00
4
2025-07-31
High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cance
-
2024-520154-38-00
5
2025-07-29
Acute Myeloid Luekemia
-
2024-511964-95-00
4
2025-07-28
Decompensated liver cirrhosis
-
2024-515098-93-00
5
2025-07-22
Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML
-
2024-517568-48-00
5
2025-07-21
Delayed Graft Function after Kidney Transplantation
-
2024-516162-11-00
5
2025-07-14
Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3CA)-Mutated, Ho